High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer
- PMID: 17210718
- DOI: 10.1158/0008-5472.CAN-06-3388
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer
Abstract
In a prospective study, we have examined the tumor-specific immune response in a group of 59 patients with human papillomavirus (HPV) 16-positive (HPV16(+))-induced or HPV18(+)-induced cervical cancer. Local antitumor immunity was analyzed by the enumeration of tumor-infiltrating dendritic cells and CD4+, CD8+, and regulatory T cells as well as by calculation of the ratio of CD8+/CD4+ T cells and CD8+/regulatory T cells. Systemic tumor-specific immunity was assessed by determination of the HPV E6- and/or E7-specific T-cell response in the blood of these patients. Finally, these variables were evaluated with respect to known histopathologic prognostic variables, including the absence (LN-) or presence (LN+) of lymph node metastases. Stratification according to the lymph node status of patients revealed a significantly stronger CD8+ T-cell tumor infiltration, a higher CD8+/CD4+ T-cell ratio, and higher CD8+/regulatory T-cell ratio in the group of patients in which the tumor failed to metastasize to the tumor-draining lymph node. Subdivision according to the presence (IR+) or absence (IR-) of circulating HPV-specific T cells disclosed that the highest number of tumor-infiltrating CD8+ T cells was found in the group of LN- patients displaying a concomitant systemic tumor-specific immune response (LN-IR+). CD8+ T-cell infiltration in LN-IR- patients was comparable with that of LN+ patients. In cervical cancer, the absence of lymph node metastases is strongly associated with a better prognosis. Our data indicate that, especially in a subgroup of LN- patients, a strong and effective interaction between immune system and tumor exists. This subgroup of cervical cancer patients may have the best prognosis.
Similar articles
-
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.Clin Cancer Res. 2008 Jan 1;14(1):178-87. doi: 10.1158/1078-0432.CCR-07-1880. Clin Cancer Res. 2008. PMID: 18172269 Clinical Trial.
-
An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer.Cancer Res. 2010 Apr 1;70(7):2707-17. doi: 10.1158/0008-5472.CAN-09-4299. Epub 2010 Mar 16. Cancer Res. 2010. PMID: 20233872
-
Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.J Immunother. 2007 Jul-Aug;30(5):523-32. doi: 10.1097/CJI.0b013e31803240fa. J Immunother. 2007. PMID: 17589293
-
Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.J Obstet Gynaecol Res. 2007 Apr;33(2):103-13. doi: 10.1111/j.1447-0756.2007.00492.x. J Obstet Gynaecol Res. 2007. PMID: 17441881 Review.
-
Host immune responses to cervical cancer.Curr Opin Obstet Gynecol. 2009 Feb;21(1):54-9. doi: 10.1097/GCO.0b013e32831a9890. Curr Opin Obstet Gynecol. 2009. PMID: 19125004 Review.
Cited by
-
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy.Mol Ther Oncolytics. 2021 Apr 2;21:144-157. doi: 10.1016/j.omto.2021.03.014. eCollection 2021 Jun 25. Mol Ther Oncolytics. 2021. PMID: 33981830 Free PMC article.
-
The Effects of Gynecological Tumor Irradiation on the Immune System.Cancers (Basel). 2024 Aug 9;16(16):2804. doi: 10.3390/cancers16162804. Cancers (Basel). 2024. PMID: 39199577 Free PMC article. Review.
-
Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield.Cancers (Basel). 2020 Jul 28;12(8):2087. doi: 10.3390/cancers12082087. Cancers (Basel). 2020. PMID: 32731404 Free PMC article. Review.
-
Influence of chemoradiation on the immune microenvironment of cervical cancer patients.Strahlenther Onkol. 2023 Feb;199(2):121-130. doi: 10.1007/s00066-022-02007-z. Epub 2022 Oct 17. Strahlenther Onkol. 2023. PMID: 36251031 Free PMC article.
-
Highlights into historical and current immune interventions for cancer.Int Immunopharmacol. 2023 Apr;117:109882. doi: 10.1016/j.intimp.2023.109882. Epub 2023 Feb 27. Int Immunopharmacol. 2023. PMID: 36848790 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous